The best menopause hormone therapy depends on symptoms, uterus status, age, time since menopause, risk factors, and personal preference. For many healthy people under 60 or within 10 years of menopause, systemic estrogen is the most effective option for hot flashes, with progesterone added if the uterus is intact 1.
Not sure where to start? Take the 3-min clinical quiz.
See if you qualify →How did we evaluate the best menopause hormone therapy options?
Menopause hormone therapy should be judged by the symptom it is meant to help, the evidence behind it, safety fit, route, clinician oversight, and cost. There is no single best option for every person, because menopause symptoms and risk factors vary.
- Efficacy evidence: strongest weight was given to hormone therapies and non-hormonal medicines studied for vasomotor symptoms, genitourinary syndrome of menopause, and bone outcomes 1.
- Safety: we considered contraindications, uterine status, clot risk, stroke risk, breast cancer history, liver disease, and unexplained bleeding 2.
- Route: oral, transdermal, local, cream, and injection options can have different exposure patterns and practical trade-offs 1.
- Access: prescription hormone therapy should involve a licensed clinician, whether care is in person or online.
- Chia fit: we included what Chia actually offers today: HRT for Women, estradiol, and progesterone options, when clinically appropriate.
What does “best menopause hormone therapy” really mean?
Best menopause hormone therapy means best matched to your main symptom and health history. A person with severe hot flashes may need a different plan than someone whose main concern is vaginal dryness or early postmenopausal bone loss.
Best for hot flashes and night sweats
For moderate to severe vasomotor symptoms, meaning hot flashes and night sweats, systemic estrogen is considered the most effective treatment in major menopause reviews and guidelines 1, 2. Side effects and risks can include breast tenderness, nausea, headache, irregular bleeding, blood clots, stroke, and regimen-specific breast cancer risk, so clinician screening matters 1.
Best for vaginal or urinary symptoms
When symptoms are mainly vaginal dryness, pain with sex, recurrent irritation, or urinary discomfort, local vaginal estrogen is often used because it acts mainly in the vaginal and urinary tissues 1. It still requires a clinician review, especially if there is unexplained bleeding, a cancer history, or complex pelvic symptoms 2.
Best for bone protection
Systemic menopausal hormone therapy can prevent early postmenopausal bone loss and reduce fractures in selected patients, but it is not started only to prevent heart disease 1, 2. Bone decisions also depend on fracture risk, age, other medicines, and side effects such as bleeding, breast tenderness, and clot risk.
Best fit based on safety, preferences, and medical history
The right choice depends on whether you have a uterus, your last menstrual period, your age, your personal and family history, and which route you prefer. If you want a broader overview, our guide to what hormone replacement therapy is for women explains the basics in plain language.
1. Is systemic estrogen best for hot flashes and night sweats?
Systemic estrogen is often the best-studied hormone option for moderate to severe hot flashes and night sweats. It circulates through the body and can help symptoms driven by the menopause-related fall in estrogen 1.
- Best for: frequent or disruptive hot flashes, night sweats, and related sleep disruption.
- Key forms: oral estrogen, transdermal estradiol patch, gel or cream-based systemic preparations, and clinician-selected injection options.
- Evidence: menopause guidelines describe MHT as the most effective treatment for vasomotor symptoms 2.
- Cautions: systemic estrogen is not appropriate for everyone, especially with certain cancer histories, unexplained vaginal bleeding, active or prior clot risk, stroke, high-risk cardiovascular disease, or active liver disease 2.
Timing matters. Reviews and guidelines report that the benefit-risk balance is often more favorable for symptomatic people who are younger than 60 or within 10 years of menopause, when there are no contraindications 1, 2. Individual results vary, and side effects can include nausea, breast tenderness, headache, bloating, mood changes, and irregular bleeding.
2. Is local vaginal estrogen best for dryness, pain with sex, and urinary symptoms?
Local vaginal estrogen is often the best hormonal fit when symptoms are mostly genital or urinary, not whole-body hot flashes. This symptom group is called genitourinary syndrome of menopause.
Low-dose local vaginal estrogen is used for vaginal dryness, irritation, pain with sex, and some urinary symptoms because it has lower systemic exposure than systemic estrogen 1. Side effects can include local irritation, discharge, spotting, or breast tenderness; unexplained bleeding should be checked by a clinician 2.
This route is different from systemic estrogen. If you also have severe hot flashes, a clinician may discuss a systemic option, a non-hormonal option, or a combination plan based on your risks and goals.
3. Is estrogen plus progesterone best if you still have a uterus?
Estrogen plus progesterone is usually the right hormone framework when systemic estrogen is used and the uterus is intact. Progesterone protects the uterine lining from estrogen-driven overgrowth.
Estrogen can stimulate the endometrium, the lining of the uterus. Adding a progestogen such as progesterone lowers the risk of endometrial hyperplasia and endometrial cancer in people with a uterus 1, 2.
Progesterone can also affect bleeding patterns and may cause sleepiness, dizziness, mood changes, breast tenderness, or bloating. Some people tolerate one progestogen better than another, so follow-up is part of safe care.
If you have had a hysterectomy, estrogen alone may be considered because there is no uterine lining to protect, unless there are other clinical reasons to use a progestogen 1. For a deeper explanation, see our guides to estradiol and progesterone.
4. Is the estradiol patch better than pills?
Transdermal estradiol patches deliver 17 beta-estradiol through the skin and avoid first-pass liver metabolism. For some people, that makes the patch a better fit than oral estrogen.
Route matters because oral estrogen goes through the liver first, which can affect clotting proteins, triglycerides, and inflammation markers. Reviews note that low- to moderate-dose transdermal estradiol may be favored when thrombotic or cardiometabolic risk is a concern 1.
The patch is not automatically safest for everyone. It can cause skin irritation, adhesive reactions, breast tenderness, headache, nausea, or bleeding changes, and systemic estrogen risks still require clinician review 1, 2.
5. What if hormone therapy is not a good fit?
Fezolinetant is a non-hormonal prescription option studied for moderate to severe vasomotor symptoms in people considered unsuitable for hormone therapy. It acts on neurokinin 3 receptors involved in the hot-flash pathway.
In a phase 3b randomized trial, fezolinetant reduced moderate to severe vasomotor symptoms in people who were unsuitable for hormone therapy 7. It can have side effects and requires attention to liver safety monitoring and medication interactions, so it is not a do-it-yourself option.
Other non-hormonal supports may include cognitive behavioral therapy for sleep and symptom coping, cooling strategies, trigger tracking, and treatment of coexisting sleep or mood conditions. Supplements vary in evidence; a randomized trial found ashwagandha improved climacteric symptom scores in perimenopausal women, but this should be viewed as limited complementary evidence, not a replacement for medical care 8.
3-min quiz
Considering menopause hormone therapy?
Chia offers online clinician review for HRT for Women, estradiol, and progesterone when clinically appropriate. A prescription requires a licensed US provider evaluation and is not guaranteed. Compounded medications are not FDA-approved; when prescribed, they are prepared by state-licensed 503A compounding pharmacies and shipped to your door.
How do pills, patches, creams, and injections compare?
Hormone therapy routes differ in how medication enters the body, how steady levels may feel, and what risks a clinician considers. The best route is the one that fits the symptom target, safety profile, and follow-up plan.
| Route | Common use | Potential advantages | Cautions | Who may ask about it |
|---|---|---|---|---|
| Oral estrogen | Systemic hot flashes, night sweats, and selected bone-related goals | Easy to take; long clinical history | More first-pass liver effect; not right for some clot, stroke, triglyceride, or liver-risk profiles 1 | Someone who wants a pill and has low risk after clinician review |
| Transdermal estradiol patch | Systemic vasomotor symptoms | Steady skin delivery; avoids first-pass liver metabolism | Skin irritation; systemic estrogen risks still apply 1 | Someone with cardiometabolic or clot-risk factors to discuss |
| Creams or local therapy | Vaginal dryness, pain with sex, urinary discomfort; some compounded systemic uses | Can target local tissue or fit people who dislike pills | Irritation, spotting, variable use patterns; route must match the goal | Someone whose symptoms are mostly vaginal or urinary |
| Progesterone | Endometrial protection when systemic estrogen is used and uterus is intact | Protects uterine lining; may affect sleep in some patients | Sleepiness, dizziness, mood changes, bloating, bleeding changes 2 | Someone with a uterus using systemic estrogen |
| Injections | Clinician-selected systemic therapy in certain compounded care plans | May fit people who prefer less frequent administration | Route, dose, and monitoring matter; not appropriate for everyone | Someone who can follow injection instructions and monitoring |
Who may be a good candidate for menopause hormone therapy?
Good candidates are often people with bothersome menopause symptoms who have no contraindications after a clinician review. Many guidelines describe a more favorable benefit-risk profile when treatment starts before age 60 or within 10 years of menopause 2.
- People with moderate to severe hot flashes or night sweats that disrupt sleep, work, or daily life.
- People in early menopause or premature ovarian insufficiency, where hormone therapy may be discussed until the usual age of menopause unless contraindicated 2.
- People with an intact uterus who understand why progesterone is usually paired with systemic estrogen 1.
- People without red flags such as unexplained vaginal bleeding, active liver disease, active clotting problems, stroke history, or certain estrogen-dependent cancers 2.
Before prescribing, clinicians should review lifestyle factors, mental health history, family history, breast cancer, endometrial cancer, liver disease, cardiovascular disease, diabetes, osteoporosis, and venous thromboembolism risk 2. That review is what turns a general option into a safer personal plan.
What age is too late to take estrogen?
There is no single age cutoff that applies to everyone. But starting systemic estrogen later in life, or more than 10 years after menopause, usually requires a more careful risk-benefit discussion.
The timing hypothesis is one reason age matters. In the ELITE randomized trial, early versus late postmenopausal estradiol treatment had different vascular effects, supporting the idea that timing since menopause changes the discussion 6.
Systemic hormone therapy should not be started for cardiovascular disease prevention 1. For someone over 60, a clinician may still consider symptoms, route, dose, and alternatives, but the review is more individualized.
Who should avoid systemic menopause hormone therapy or use extra caution?
Systemic MHT is not appropriate for every patient. A licensed clinician needs to screen for contraindications before any prescription.
- History of breast cancer or certain estrogen-dependent cancers.
- Unexplained vaginal bleeding that has not been evaluated.
- Active or prior venous thromboembolism, stroke, or high-risk cardiovascular disease.
- Active liver disease or other major risk factors.
- Medication interactions or medical histories that change the risk-benefit balance 2.
This is also why celebrity regimens are not useful medical guidance. Even if a public figure says they use a menopause treatment, their diagnosis, screening, dose, formulation, and risks are private and cannot guide another person’s care.
Menopause hormone therapy at Chia: online estradiol and progesterone options
Chia HRT care is 100% online: you complete a health questionnaire, then a licensed US provider reviews your symptoms, uterus status, medical history, medications, and risk factors. A prescription is never guaranteed and is provided only when clinically appropriate.
At Chia, the HRT for Women protocol includes Estradiol Oral + Progesterone IR and plans currently start at $119/mo. We also offer estradiol as cream, injection from $109/mo, and transdermal patch, and progesterone as cream and injection from $109/mo.
| Chia option | Forms listed in Chia’s catalog | Current starting price | How it may fit |
|---|---|---|---|
| HRT for Women | Estradiol Oral + Progesterone IR | From $119/mo | A combined protocol for eligible patients when a provider finds estrogen plus progesterone appropriate |
| Estradiol | Cream, injection, transdermal patch | Injection from $109/mo | May be considered for menopause symptoms when estrogen therapy fits the patient’s history |
| Progesterone | Cream, injection | Injection from $109/mo | May be used when progesterone is clinically appropriate, including endometrial protection needs |
When prescribed, Chia medications are compounded in the US by state-licensed 503A compounding pharmacies and shipped to your door. Dosing is provider-guided and adjusted over time; patients can message their care team through the patient portal between visits. For more context, see our guide to online hormone replacement therapy for women.
How should you prepare for a menopause hormone therapy visit?
A good HRT visit starts with clear symptom tracking and honest medical history. The goal is not just to get a prescription; it is to match the route and plan to your risks and goals.
- 1Track hot flashes, night sweats, sleep disruption, vaginal dryness, urinary symptoms, mood changes, and bleeding for 1 to 2 weeks.
- 2Write down your last menstrual period, whether you still have a uterus, and any history of hysterectomy, endometriosis, fibroids, or abnormal bleeding.
- 3List personal and family history of breast cancer, endometrial cancer, blood clots, stroke, heart disease, liver disease, osteoporosis, diabetes, migraine, and smoking.
- 4Bring your medication and supplement list, including over-the-counter products.
- 5Ask how route, dose, follow-up, bleeding changes, side effects, and stopping rules will be handled.
If you are comparing care models, our overview of hormone therapy for menopause symptoms may help you decide what to ask during your visit.
3-min quiz
Start an online menopause HRT review
If you are considering menopause hormone therapy, Chia can review your symptoms and health history online. If a licensed US provider determines treatment is appropriate, compounded medication is prepared by a state-licensed 503A pharmacy and shipped to your door. A prescription is not guaranteed.
FAQ
Gynecologists usually start by matching treatment to the main symptom. Systemic estrogen is often used for moderate to severe hot flashes and night sweats when appropriate. Local vaginal estrogen may be used for vaginal or urinary symptoms. Progesterone is usually added if systemic estrogen is used and the uterus is intact.
A celebrity’s personal menopause regimen cannot be verified or used to guide your care. Menopause hormone therapy depends on symptoms, uterus status, age, time since menopause, medical history, and contraindications.
Estrogen is usually the main hormone for hot flashes and night sweats. Progesterone is usually used with systemic estrogen when the uterus is intact to protect the uterine lining. The right choice depends on your anatomy and goals.
There is no single safest form for everyone. Transdermal estradiol may be preferred for some people when clot or cardiometabolic risk is a concern, while local vaginal estrogen may be preferred when symptoms are only vaginal or urinary. A clinician should review your risks before prescribing.
The estradiol patch avoids first-pass liver metabolism and may fit some patients better than oral estrogen. Pills may still be appropriate for others. The best route depends on symptoms, risks, preference, and follow-up.
Sometimes, but starting systemic hormone therapy after 60 usually needs a more careful risk-benefit review. Age, years since menopause, cardiovascular risk, clot risk, cancer history, and symptom severity all matter.
Often no, because progesterone is mainly used to protect the uterine lining when systemic estrogen is used. There may be exceptions, so the decision should be made with a licensed clinician.
Yes, online menopause hormone therapy is possible when a licensed clinician can review your history and determine whether treatment is appropriate. At Chia, prescriptions are not guaranteed. Compounded drugs are not FDA-approved and are prepared by state-licensed 503A pharmacies when prescribed.
References
- 1.Menopausal Hormone Therapy—Risks, Benefits and Emerging Options. PMC, 2025.
- 2.The 2020 Menopausal Hormone Therapy Guidelines. Journal of Menopausal Medicine, 2020.
- 3.U.S. Food and Drug Administration. HHS Advances Women’s Health, Removes Misleading FDA Warnings on Hormone Replacement Therapy. FDA News Release, 2025.
- 4.FDA’s 2025 removal of black box warnings on menopausal hormone therapy. PMC, 2025.
- 5.Genazzani AR, Monteleone P, Giannini A, et al. Hormone therapy in the postmenopausal years: considering benefits and risks in clinical practice. Human Reproduction Update, 2021.
- 6.Hodis HN, Mack WJ, Henderson VW, et al. Vascular Effects of Early versus Late Postmenopausal Treatment with Estradiol. The New England Journal of Medicine, 2016.
- 7.Schaudig K, Wang X, Bouchard C, et al. Efficacy and safety of fezolinetant for moderate-severe vasomotor symptoms associated with menopause in individuals unsuitable for hormone therapy: phase 3b randomised controlled trial. BMJ, 2024.
- 8.Gopal S, Ajgaonkar A, Kanchi P, et al. Effect of an ashwagandha (Withania Somnifera) root extract on climacteric symptoms in women during perimenopause: A randomized, double-blind, placebo-controlled study. Journal of Obstetrics and Gynaecology Research, 2021.
- 9.Lantto H, Haapalahti P, Viitasalo M, et al. Vasomotor hot flashes and cardiac repolarization: a randomized placebo-controlled trial of postmenopausal hormone therapy. Menopause, 2017.
- 10.Sun AJ, Wang YP, Gu B, et al. A Multi-center, Randomized, Controlled and Open Clinical Trial of Heyan Kuntai Capsule and Hormone Therapy in Perimenopausal Women. Chinese Journal of Integrative Medicine, 2018.
About this article
Chia Health Editorial Team — Evidence-reviewed health education
This article is for educational purposes only and is not a substitute for individualized medical advice. Talk to a licensed clinician before starting, stopping, or changing any prescription.
AI tools may assist with research and drafting. Chia's editorial team reviews source use, clarity, treatment information, and safety framing before publication. A clinician is named only after explicit sign-off. Read our editorial standards.
Get a personalized plan
Find what fits your body and your goals.
Our 3-minute clinical quiz is reviewed by a US-licensed clinician. Treatment delivered to your door.



